Biomx inc. (CHAC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Mar'18
Research and development ("R&D") expenses, net

3,908

-

-

-

2,743

-

-

-

General and administrative expenses

2,058

-

-

-

981

-

-

-

Operating costs

-

-

618

294

93

15

0

1

Operating Loss

-5,966

-21,199

-618

3,335

-3,724

-15

-0

-1

Finance income, net

65

-

-

-

499

-

-

-

Interest income on marketable securities held in Trust Account

-

-

372

-

-

-

-

-

Interest income - other

-

-

2

-

-

55

-

-

Unrealized loss on marketable securities held in Trust Account

-

-

-

-

-

-21

-

-

Other income

-

-

374

-

-

34

-

-

Loss before income tax

-

-20,783

-244

114

349

18

-0

-1

Income tax

-

-

47

-

-

8

-

-

Net Loss

-5,901

-20,608

-292

3,562

-3,225

10

-0

-1

Basic and diluted loss per Ordinary Shares

0.26

4.06

-0.25

-2.35

2.20

0.00

0.00

0.00

Weighted average number of Ordinary Shares outstanding, basic and diluted

22,897

15,804

2,239

2,414

2,005

1,815

1,750

1,750